切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2024, Vol. 18 ›› Issue (03) : 225 -228. doi: 10.3877/cma.j.issn.1674-0793.2024.03.010

综述

T1和T2期胆囊癌外科治疗研究进展
张锐1, 赵舸2,()   
  1. 1. 030001 太原,山西医科大学
    2. 030001 太原,山西医科大学第二医院普通外科
  • 收稿日期:2023-07-27 出版日期:2024-06-01
  • 通信作者: 赵舸

Progress in the surgical treatment of T1- and T2-stage gallbladder cancers

Rui Zhang1, Ge Zhao2,()   

  1. 1. Shanxi Medical University, Taiyuan 030001, China
    2. Department of General Surgery, the Second Hospital of Shanxi Medical University, Taiyuan 030001, China
  • Received:2023-07-27 Published:2024-06-01
  • Corresponding author: Ge Zhao
引用本文:

张锐, 赵舸. T1和T2期胆囊癌外科治疗研究进展[J/OL]. 中华普通外科学文献(电子版), 2024, 18(03): 225-228.

Rui Zhang, Ge Zhao. Progress in the surgical treatment of T1- and T2-stage gallbladder cancers[J/OL]. Chinese Archives of General Surgery(Electronic Edition), 2024, 18(03): 225-228.

T1、T2期胆囊癌处于局部早中期,手术切除是首选治疗方法,通过制定合理的手术方案,多数患者预后良好。目前,国内外在Tis及T1a期胆囊癌治疗上已达成共识,但T1b、T2a、T2b期胆囊癌的治疗策略仍存在许多争议,尤其是在肝脏切除和淋巴结清扫范围上没有明确的共识。因此,外科医师应针对不同的患者,需要充分评估和预测,制定适合患者的最佳治疗方案,以获得更好的预后。

T1- and T2-stage gallbladder cancer belongs to early and middle stage, and surgical resection is the first choice of treatment. By formulating reasonable surgical methods, most patients have good prognosis. At present, there is consensus on the treatment of Tis and T1a patients at home and abroad, but there are still many disputes on the treatment strategy of T1b, T2a and T2b patients, especially on the scope of hepatectomy and lymph node dissection. Therefore, surgeons need to fully evaluate, predict, and formulate the optimal treatment plans for different patients to achieve better prognosis.

[1]
李奇为, 季福. 胆囊癌Nevin分期与AJCC分期的临床应用价值比较[J]. 中华普通外科杂志, 2009, 24(7): 521-524.
[2]
Chun YS, Pawlik TM, Vauthey JN. 8th Edition of the AJCC Cancer Staging Manual: pancreas and hepatobiliary cancers[J]. Ann Surg Oncol, 2018, 25(4): 845-847.
[3]
李茂岚, 刘颖斌. 胆囊癌诊治进展[J]. 肝胆外科杂志, 2019, 27(5): 326-328.
[4]
钱昌林, 刘颖斌. TNM分期在胆囊癌根治性切除术中地位和作用[J]. 中国实用外科杂志, 2022, 42(9): 1046-1050.
[5]
Benson AB, D’Angelica MI, Abbott DE, et al. Guidelines insights: hepatobiliary cancers, Version 2.2019[J]. J Natl Compr Canc Netw, 2019, 17(4): 302-310.
[6]
Nagino M, Hirano S, Yoshitomi H, et al. Clinical practice guidelines for the management of biliary tract cancers 2019: the 3rd English edition[J]. J Hepatobiliary Pancreat Sci, 2021, 28(1): 26-54.
[7]
Kim BH, Kim SH, Song IS, et al. The appropriate surgical strategy for T1b gallbladder cancer incidentally diagnosed after a simple cholecystectomy[J]. Ann Hepatobiliary Pancreat Surg, 2019, 23(4): 327-333.
[8]
Yuza K, Sakata J, Prasoon P, et al. Long-term outcomes of surgical resection for T1b gallbladder cancer: An institutional evaluation[J]. BMC Cancer, 2020, 20(1): 20.
[9]
Lee SE, Jang JY, Lim CS, et al. Systematic review on the surgical treatment for T1 gallbladder cancer[J]. World J Gastroenterol, 2011, 17(2): 174-180.
[10]
Xu L, Tan H, Liu X, et al. Survival benefits of simple versus extended cholecystectomy and lymphadenectomy for patients with T1b gallbladder cancer: An analysis of the surveillance, epidemiology, and end results database (2004 to 2013)[J]. Cancer Med, 2020, 9(11): 3668-3679.
[11]
Ren T, Li YS, Dang XY, et al. Prognostic significance of regional lymphadenectomy in T1b gallbladder cancer: results from 24 hospitals in China[J]. World J Gastrointest Surg, 2021, 13(2): 176-186.
[12]
吴昕, 洪涛, 李秉璐, 等. T2a期胆囊癌联合或不联合肝脏切除治疗的效果分析[J]. 中国普外基础与临床杂志, 2022, 29(11): 1458-1462.
[13]
Kang H, Choi YS, Suh SW, et al. Prognostic significance of tumor location in T2 gallbladder cancer: A systematic review and meta-analysis[J]. J Clin Med, 2021, 10(15): 3317.
[14]
Lee SE, Choi YS, Kim YH, et al. Prognostic significance of tumor location in T2 gallbladder cancer: A Korea Tumor Registry System Biliary Pancreas (KOTUS-BP) database analysis[J]. J Clin Med, 2020, 9(10): 3268.
[15]
Lafaro K, Blakely AM, Melstrom LG, et al. Prognostic impact of tumor location in resected gallbladder cancer: A national cohort analysis[J]. J Surg Oncol, 2020, 122(6): 1084-1093.
[16]
中华医学会外科学分会胆道外科学组, 中国医师协会外科医师分会胆道外科专业委员会. 胆囊癌诊断和治疗指南(2019版)[J]. 中华外科杂志, 2020, 58(4): 243-251.
[17]
Chen M, Cao J, Xiang Y, et al. Hepatectomy strategy for T2 gallbladder cancer between segment Ⅳb and Ⅴ resection and wedge resection: A propensity score-matched study[J]. Surgery, 2021, 169(6): 1304-1311.
[18]
Zhang W, Huang Z, Wang WE, et al. Survival benefits of simple versus extended cholecystectomy and lymphadenectomy for patients with T2 gallbladder cancer: A propensity-matched population-based study (2010 to 2015)[J]. Front Oncol, 2021, 11: 705299.
[19]
Lee W, Jeong CY, Jang JY, et al. Do hepatic-sided tumors require more extensive resection than peritoneal-sided tumors in patients with T2 gallbladder cancer? Results of a retrospective multicenter study[J]. Surgery, 2017, 162(3): 515-524.
[20]
Sternby Eilard M, Lundgren L, Cahlin C, et al. Surgical treatment for gallbladder cancer - a systematic literature review[J]. Scand J Gastroenterol, 2017, 52(5): 505-514.
[21]
Goetze TO, Paolucci V. Incidental T1b-T3 gallbladder carcinoma. Extended cholecystectomy as an underestimated prognostic factor-results of the German registry[J]. Chirurg, 2014, 85(2): 131-138.
[22]
Köhn N, Maubach J, Warschkow R, et al. High rate of positive lymph nodes in T1a gallbladder cancer does not translate to decreased survival: A population-based, propensity score adjusted analysis[J]. HPB (Oxford), 2018, 20(11): 1073-1081.
[23]
Goel M, Pandrowala S, Patel P, et al. Node positivity in T1b gallbladder cancer: A high volume centre experience[J]. Eur J Surg Oncol, 2022, 48(7): 1585-1589.
[24]
Wang Z, Li Y, Jiang W, et al. Simple cholecystectomy is adequate for patients with T1b gallbladder adenocarcinoma < 1 cm in diameter[J]. Front Oncol, 2019, 9: 409.
[25]
Shao J, Lu HC, Wu LQ, et al. Simple cholecystectomy is an adequate treatment for grade Ⅰ T1bN0M0 gallbladder carcinoma: evidence from 528 patients[J]. World J Gastroenterol, 2022, 28(31): 4431-4441.
[26]
Li G, Kim JH, Jung W, et al. Significance of hepatectomy in patients diagnosed with T2 gallbladder cancer[J]. Surg Laparosc Endosc Percutan Tech, 2020, 30(1): 35-39.
[27]
Toge K, Sakata J, Hirose Y, et al. Lymphatic spread of T2 gallbladder carcinoma: regional lymphadenectomy is required independent of tumor location[J]. Eur J Surg Oncol, 2019, 45(8): 1446-1452.
[28]
Shirai Y, Sakata J, Wakai T, et al. Assessment of lymph node status in gallbladder cancer: location, number, or ratio of positive nodes[J]. World J Surg Oncol, 2012, 10: 87.
[29]
Miyazaki M, Ohtsuka M, Miyakawa S, et al. Classification of biliary tract cancers established by the Japanese Society of Hepato-Biliary-Pancreatic Surgery: 3(rd) English edition[J]. J Hepatobiliary Pancreat Sci, 2015, 22(3): 181-196.
[1] 钟锴, 蒋铁民, 张瑞青, 吐尔干艾力·阿吉, 邵英梅, 郭强. 加速康复外科在肝囊型棘球蚴病肝切除术中的应用分析[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 425-429.
[2] 冷建军, 朴成林, 司振铎. 胰十二指肠切除术联合小范围肝切除、血管切除重建[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 384-384.
[3] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[4] 冯旺, 马振中, 汤林花. CT扫描三维重建在肝内胆管细胞癌腹腔镜肝切除术中的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 104-107.
[5] 赖全友, 高远, 汪建林, 屈士斌, 魏丹, 彭伟. 三维重建技术结合腹腔镜精准肝切除术对肝癌患者术后CD4+、CD8+及免疫球蛋白水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 651-654.
[6] 唐梅, 周丽, 牛岑月, 周小童, 王倩. ICG荧光导航的腹腔镜肝切除术临床意义[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 655-658.
[7] 贺斌, 马晋峰. 胃癌脾门淋巴结转移危险因素[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 694-699.
[8] 胡森焱, 徐冬, 方健, 谢冬冬, 王财庆. ICG荧光显影Laennec膜入路腹腔镜解剖性肝切除的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 513-516.
[9] 林巧, 周丽. RFA联合LAH术治疗原发性肝癌并门静脉癌栓的临床效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 521-524.
[10] 曾繁利, 齐秩凯, 杨贺庆. 两种经Glisson蒂鞘解剖路径肝切除术治疗原发性肝癌的肿瘤学疗效及风险比对[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 525-527.
[11] 林逸, 钟文龙, 李锴文, 何旺, 林天歆. 广东省医学会泌尿外科疑难病例多学科会诊(第15期)——转移性膀胱癌的综合治疗[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 648-652.
[12] 杭轶, 杨小勇, 李文美, 薛磊. 可控性低中心静脉压技术在肝切除术中应用的最适中心静脉压[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 813-817.
[13] 焦振东, 惠鹏, 金上博. 三维可视化结合ICG显像技术在腹腔镜肝切除术治疗复发性肝癌中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 859-864.
[14] 吴警, 吐尔洪江·吐逊, 温浩. 肝切除术前肝功能评估新进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 889-893.
[15] 吴雪云, 胡小军, 范应方. 肝切除术中剩余肝再生能力的评估与预测[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 894-897.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?